NIBEC Co., Ltd. (KOSDAQ:138610)
19,220
+510 (2.73%)
At close: Jun 12, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 218.49 billion as of June 12, 2026. Its market cap has decreased by -2.33% in one year.
Market Cap
218.49B
Enterprise Value
204.02B
Revenue
32.34B
Ranking
n/a
PE Ratio
29.94
Stock Price
19,220.00
Market Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 218.49B, an increase of 483.67%. That is a compound annual growth rate of 12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 218.49B | -48.79% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 255.97B |
| Kangstem Biotech | 253.48B |
| curacle co.,ltd. | 252.45B |
| Genome & Company | 251.71B |
| Y-Biologics | 205.66B |
| ViGenCell | 190.03B |
| Bio Solution | 183.21B |
| Ensol Biosciences | 170.41B |